Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.
about
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Bevacizumab as a last-line tre ...... y, temozolomide and lomustine.
@en
type
label
Bevacizumab as a last-line tre ...... y, temozolomide and lomustine.
@en
prefLabel
Bevacizumab as a last-line tre ...... y, temozolomide and lomustine.
@en
P2093
P2860
P356
P1433
P1476
Bevacizumab as a last-line tre ...... py, temozolomide and lomustine
@en
P2093
Emmanouil Fokas
Joachim P Steinbach
Katharina J Wenger
Marlies Wagner
Martin Voss
Michael C Burger
Oliver Bähr
Se-Jong You
P2860
P304
P356
10.3892/OL.2017.6251
P577
2017-05-25T00:00:00Z